Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FZ5BE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,789
Award facts
- Contract value 100% obligated
- $23,788.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,788.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 4,570,729,319 units of Cosentyx Unoready 300 mg pens (2 mL) on February 4, 2026, with completion scheduled for February 5, 2026. The contract utilizes no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent organization being Cencora, Inc. (doing business as AmerisourceBergen). This delivery order falls under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical program, which provides critical pharmaceutical supply support to military healthcare systems globally.
The DLA's pharmaceutical acquisition through AmerisourceBergen supports the Defense Health Agency and military treatment facilities' ongoing medical supply needs. AmerisourceBergen holds a significant $999,999,999 IDC with DLA Troop Support Medical extending through December 2026, positioning the company as a key vendor for federal military pharmaceutical procurement. The contractor's portfolio encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, reflecting its substantial role in sustaining military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FZ5BE?
SPE2DR26FZ5BE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FZ5BE worth?
The government has obligated $23,789 on SPE2DR26FZ5BE.
Is contract SPE2DR26FZ5BE an order under another contract?
Yes. SPE2DR26FZ5BE is a delivery order under SPE2DR25D1050, an indefinite delivery contract.
Was contract SPE2DR26FZ5BE competed?
The extent of competition for SPE2DR26FZ5BE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award